Personalized Medicine

WTF Health: Accolade Navigates Itself into New Territory: CEO on Personalized Healthcare & Tech Infrastructure

By JESSICA DaMASSA, WTF HEALTH Healthcare navigator Accolade (NASDAQ:ACCD) is on the move. Not only are they now cruising in care delivery territory with two new primary care/mental healthcare offerings that let them personally guide their 9M members further into the healthcare system, BUT they’re also starting to talk more and more about their tech …

WTF Health: Accolade Navigates Itself into New Territory: CEO on Personalized Healthcare & Tech Infrastructure Read More »

Genetika+ Raises $10M for Personalized Medicine for Psychiatry Solution

Genetika+ Co-Founders Talia Cohen-Solal, Ph.D., and Daphna Laifenfeld, Ph.D What You Should Know:  – Genetika+, a female-founded startup focused on developing personalized medicine for psychiatry conditions, that the company has closed a $10 million Series A round led by GreyBird Ventures with participation from Meron Capital, Jumpspeed Ventures, Sapir Venture Partners, Howard Morgan Chairman of …

Genetika+ Raises $10M for Personalized Medicine for Psychiatry Solution Read More »

Rising Demand for Customized Medication To Transform Compounding Pharmacies Market Outlook

Compounding pharmacies, which involve the preparation and selling of prescribed medicines are gaining massive popularity across the healthcare sector owing to the rising awareness regarding the benefits of compounded medications. Besides, the shortfall of various drugs such as cancer medicines and other lifesaving drugs is fostering the demand for compounding pharmacy services. With increasing proclivity …

Rising Demand for Customized Medication To Transform Compounding Pharmacies Market Outlook Read More »

What Excites You Most About the Life Sciences Industry in 2021?

We have looked back at some of the biggest advances in 2020, but it’s a new year and time to look ahead, so we asked our Life Sciences team what they are looking forward to in 2021. “Predicting the unknown!” says Thibault Géoui, Senior Director of Discovery Biology & Predictive Risk Management. “We are using …

What Excites You Most About the Life Sciences Industry in 2021? Read More »

From Analog to Digital Neurology: 3 Steps to Better Inform Patient Care

Dr. Nandor Pinter, Director of Neuroimaging Research, DENT Institute Dr. Murray Gillies, General Manager of Digital Cognitive Dx Venture, Philips The field of neurology is at an inflection point. With a growing aging population, neurologists are facing an increasing number of patients needing care, and the pent-up demand for services due to COVID-19 only exacerbates …

From Analog to Digital Neurology: 3 Steps to Better Inform Patient Care Read More »

Patient-First Model: High Tech Meets High Touch for Individuals with Rare Disorders

Donovan Quill, President and CEO, Optime Care Industry experts state that orphan drugs will be a major trend to watch in the years ahead, accounting for almost 40% of the Food and Drug Administration approvals this year. This market has become more competitive in the past few years, increasing the potential for reduced costs and broader patient accessibility. …

Patient-First Model: High Tech Meets High Touch for Individuals with Rare Disorders Read More »

Getting the right data to doctors is next hurdle for precision medicine

The future of precision medicine will come only as quickly as doctors can pick out clinically useful information from the genetic data being gathered on their patients.

3D Printing Makes Medical Devices More Personal

Personalized medicine is a major trend in pharmaceutical R&D—and it’s transforming the way we think of therapeutics. Unlocking the secrets of the genome has made it possible to create treatments for disease that are more suited to the individual. But personalized medicine isn’t a concept that only applies to drug therapies. It is also highly …

3D Printing Makes Medical Devices More Personal Read More »

3D Printing Makes Medical Devices More Personal

Personalized medicine is a major trend in pharmaceutical R&D—and it’s transforming the way we think of therapeutics. Unlocking the secrets of the genome has made it possible to create treatments for disease that are more suited to the individual. But personalized medicine isn’t a concept that only applies to drug therapies. It is also highly …

3D Printing Makes Medical Devices More Personal Read More »

NIH Taps PhysIQ to Develop AI-Based COVID-19 Digital Biomarker

What You Should Know: – physIQ has been selected by the National Institute of Health (NIH) to develop an innovative AI-based COVID-19 digital biomarker solution to address the COVID-19 pandemic. – Early detection of COVID-19 decompensation in patients is complicated by infrequent and non-specific clinical data. The first-in-kind tool will collect and analyzes continuous physiologic …

NIH Taps PhysIQ to Develop AI-Based COVID-19 Digital Biomarker Read More »